ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.98
0.86%
US Tech 100
20,877.20
1.72%
S&P 500
5,996.66
1.00%
US Dollar vs CAD
1.44905
0.03%
Bitcoin
103,114.08
-0.97%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Sight Sciences Inc (SGHT) Share Price

Sight Sciences Inc

Sight Sciences Inc (SGHT)

NASDAQ
2.83
-0.01
(-0.35%)
Closed January 18 3:00PM
Delayed by 15 minutes
2.89
0.06
(2.12%)
After Hours: 3:59PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
2.89
Bid
2.76
Ask
2.99
Volume
694,249
2.675 Day's Range 2.875
2.83 52 Week Range 8.45
Market Cap
146.681M
Previous Close
2.84
Open
2.85
Last Trade
77
@
2.89
Last Trade Time
Financial Volume
US$ 1,941,373
VWAP
2.7964
Average Volume (3m)
244,400
Shares Outstanding
50,754,616
Dividend Yield
-
PE Ratio
-2.59
Earnings Per Share (EPS)
-1.09
Revenue
81.06M
Net Profit
-55.55M

About Sight Sciences Inc

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilit... Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.sightsciences.com
Headquarters
Dover, Delaware, USA
Founded
-
Sight Sciences Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker SGHT. The last closing price for Sight Sciences was US$2.84. Over the last year, Sight Sciences shares have traded in a share price range of US$ 2.83 to US$ 8.45.

Sight Sciences currently has 50,754,616 shares outstanding. The market capitalization of Sight Sciences is US$144.14 million. Sight Sciences has a price to earnings ratio (PE ratio) of -2.59.

Ask ADVFN Intelligence (AI)

SGHT Latest News

More News

Form 144 - Report of proposed sale of securities

14 hours ago
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

15 hours ago
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

January 16 2025
Edgar (US Regulatory)

Form 8-K - Current report

January 14 2025
Edgar (US Regulatory)

Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2024 Financial Highlights

MENLO PARK, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and...

January 14 2025
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

January 10 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

January 10 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

January 10 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

January 08 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

January 08 2025
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.36-11.07692307693.253.3352.832612463.04194721CS
4-0.57-16.47398843933.463.732.832367893.35661637CS
12-2.39-45.26515151525.285.482.832444003.92677217CS
26-5.33-64.84184914848.228.452.832033725.09549662CS
52-2.21-43.33333333335.18.452.831894735.26231748CS
156-12.92-81.720430107515.8118.2451.042411856.89339882CS
260-27.11-90.36666666673042.571.0425214610.48024638CS

SGHT - Frequently Asked Questions (FAQ)

What is the current Sight Sciences share price?
The current share price of Sight Sciences is US$ 2.89
How many Sight Sciences shares are in issue?
Sight Sciences has 50,754,616 shares in issue
What is the market cap of Sight Sciences?
The market capitalisation of Sight Sciences is USD 144.14M
What is the 1 year trading range for Sight Sciences share price?
Sight Sciences has traded in the range of US$ 2.83 to US$ 8.45 during the past year
What is the PE ratio of Sight Sciences?
The price to earnings ratio of Sight Sciences is -2.59
What is the cash to sales ratio of Sight Sciences?
The cash to sales ratio of Sight Sciences is 1.77
What is the reporting currency for Sight Sciences?
Sight Sciences reports financial results in USD
What is the latest annual turnover for Sight Sciences?
The latest annual turnover of Sight Sciences is USD 81.06M
What is the latest annual profit for Sight Sciences?
The latest annual profit of Sight Sciences is USD -55.55M
What is the registered address of Sight Sciences?
The registered address for Sight Sciences is 850 NEW BURTON ROAD, SUITE 201, DOVER, DELAWARE, 19904
What is the Sight Sciences website address?
The website address for Sight Sciences is www.sightsciences.com
Which industry sector does Sight Sciences operate in?
Sight Sciences operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BTCTBTC Digital Ltd
US$ 8.2697
(73.73%)
61.45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8.80
(62.36%)
18.63M
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
NUKKNukkleus Inc
US$ 29.97
(45.98%)
19.09M
GSITGSI Technology
US$ 3.97
(44.36%)
87.7M
DOGZDogness International Corporation
US$ 18.23
(-58.77%)
740.45k
ORKTOrangeKloud Technology Inc
US$ 3.02
(-24.88%)
21.08M
PMAXPowell Max Ltd
US$ 0.6364
(-23.31%)
4.17M
LGCBLinkage Global Inc
US$ 0.2876
(-22.27%)
890.66k
YYAIConnexa Sports Technologies Inc
US$ 0.8299
(-20.20%)
602.48k
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
GCTKGlucoTrack Inc
US$ 0.0852
(15.45%)
465.22M
RIMEAlgorhythm Holdings Inc
US$ 0.0406
(-4.02%)
387.23M
TGLTreasure Global Inc
US$ 0.2459
(14.75%)
267.1M
NVDANVIDIA Corporation
US$ 137.71
(3.10%)
201.4M

SGHT Discussion

View Posts
PonkenPlonken PonkenPlonken 1 week ago
at 3$ again
will Staffan buy shares again?
👍️0
Southern Gal Southern Gal 2 months ago
I expected it and I bought puts in advance of it.
Was easy to predict

Exactly 1 year since the PPS tanked to $1
Which meant that those who held for 1 year to get LTCGT were going to dump
👍️0
RC_702 RC_702 3 months ago
Wow! Big dip today. What is up?
👍️0
RC_702 RC_702 3 months ago
Hmmm below the professionals price estimate of 5.70. Interesting. I guess you were right on that not being correct. It’s looking like it is below 5.70 .,,,
👍️0
RC_702 RC_702 3 months ago
Hmmm below the professionals price estimate of 5.70. Interesting. I guess you were right on that not being correct. It’s looking like it is below 5.70 .,,,
👍️0
Southern Gal Southern Gal 3 months ago
GOOD NEWS

https://finance.yahoo.com/news/single-tearcare-treatment-improved-functional-200500005.html
👍️0
Southern Gal Southern Gal 3 months ago
Nice movement today
👍️0
RC_702 RC_702 3 months ago
Imagine that , it’s back to target price. Maybe the pro knows something about it after all?!
👍️0
RC_702 RC_702 5 months ago
It’s just hit $5.70
👍️0
RC_702 RC_702 6 months ago
It’s closing in on the target price
👍️0
RC_702 RC_702 6 months ago
Hopefully it will bounce back
It beat estimated revenue
👍️0
RC_702 RC_702 6 months ago
Hopefully it will bounce back
👍️0
Southern Gal Southern Gal 6 months ago
Lots of trading post and premarket. Could be another good day. Earnings to be reported on 8/1

https://finance.yahoo.com/news/sight-sciences-report-second-quarter-200500099.html
👍️0
Southern Gal Southern Gal 6 months ago
Looking awesome. Getting close to a 52 week high PPS. I'm up nearly 200% on my $2.98's.

TFSBIGWS!!!
👍️0
RC_702 RC_702 6 months ago
Do you think that hold is referring to not buying the stock? Is that a possibility?

I love the way you have to dialogue with inflammatory language.
👍️0
RC_702 RC_702 6 months ago
Do you think that hold is referring to not buying the stock? Is that a possibility?

I love the way you have to dialogue with inflammatory language.
👍️0
Southern Gal Southern Gal 6 months ago
Only a fool would listen to an analyst who advises holding a stock that's trading $2.25 ABOVE their price target.
CURRENT PRICE $7.95
Price Target $5.70
ANALYST RATING:
HOLD
👍️0
Southern Gal Southern Gal 6 months ago
Oh NO!!!

47,780 shares? Out of the millions they own????

The world is coming to an end!!!

https://finance.yahoo.com/quote/SGHT/insider-roster/
👍️0
RC_702 RC_702 6 months ago
Re: the buyout you speculated about

I’m guessing that Alison Bouerlein, CFO
Jeremy Hayden , David Badawi, CTO, Paul Badawi CEO, and Sam Park CTO who are officers of sght did not know about the merger either.
They all sold shares July 1, 2 2024

47,780 shares at 5.42 to 6.21 average price per share
👍️0
Southern Gal Southern Gal 6 months ago
they're
👍️0
Southern Gal Southern Gal 6 months ago
Oh no, not another UP day!! How many am I supposed to endure?

UP $0.49
+6.27%

ANOTHER 11 month high closing PPS!

Boy- those analysts sure do know what their talking about, don't they!?!?
👍️0
RC_702 RC_702 6 months ago
I guess they don’t know about the buyout:


According to marketbeat:


UPSIDE/ DOWNSIDE
27.1% Downside
$5.70 Price Target

SHORT INTEREST
Bearish
4.09% of Float Sold Short

ANALYST RATING
Hold
2.00 Rating Score

(Sight Sciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 5 hold ratings, and 1 sell rating.)

INSIDER TRADING
Selling Shares
$290,061 Sold Last Quarter

Overall marketrank
0.50 out of 5 stars
👍️0
RC_702 RC_702 6 months ago
What happened?

Sight Sciences sets terms for IPO, to raise up to $160.5 million
Published: July 8, 2021 at 6:37 a.m. ET

Sight Sciences Inc. has set terms of its initial public offering, which could value the California-based ophthalmology and optometry company at up to $971.7 million. The company is looking to raise up to $160.54 million, as it is offering 6.98 million shares in the IPO, which is expected to price between $20 and $23 a share.
👍️0
Southern Gal Southern Gal 6 months ago
LOL

Up nearly 3%

Closed at the 11 month high pps
👍️0
Southern Gal Southern Gal 6 months ago
lol
👍️0
Southern Gal Southern Gal 6 months ago
I put more weight into my own projection- that SGHT will be acquired by a larger optical device company, like Alcon, against whom SGHT was recently awarded damages for patent infringement.

https://www.healio.com/news/ophthalmology/20240430/sight-sciences-awarded-34-million-in-patent-infringement-case-against-alcon
👍️0
RC_702 RC_702 6 months ago
Here’s where I got the information:

Sight Sciences, Inc. (SGHT)
NASDAQ: SGHT · IEX Real-Time Price · USD

Price Target
5.60 (-27.18%)
👍️0
RC_702 RC_702 6 months ago
Not my analysis, just researching what various experts have suggested about the potential stock movements of sght.

Three different sources have said not to buy and multiple sources have said year price around $6.

What do you think about the fact that the projected profitability is three years away at best?
👍️0
RC_702 RC_702 6 months ago
Perhaps JP Morgen and others that dumped all their stock was because of this:

Financial Efficiency
Return on equity (ROE) is -44.50% and return on invested capital (ROIC) is -38.09%.

I believe that would be a good call
👍️0
Southern Gal Southern Gal 6 months ago
That makes so much sense

7 analysts have a target of $5.60, which is $2 BELOW the current PPS, and yet, the 7 analysts recommending holding?

So- they recommend holding so as to lock in a 30% LOSS?
BRILLIANT!!!!

RC_702
Re: None
Monday, July 15, 2024 9:25:07 AM
Post# of 80 Go
Analyst Forecast
According to 7 analysts, the average rating for SGHT stock is "Hold." The 12-month stock price forecast is $5.6, which is a decrease of -26.41% from the latest price.

Price Target
$5.6
(-26.41% downside)
Analyst Consensus: Hold[/quote]
👍️0
RC_702 RC_702 6 months ago
Analyst Forecast
According to 7 analysts, the average rating for SGHT stock is "Hold." The 12-month stock price forecast is $5.6, which is a decrease of -26.41% from the latest price.

Price Target
$5.6
(-26.41% downside)
Analyst Consensus: Hold
👍️0
RC_702 RC_702 6 months ago
Before you buy stock in Sight Sciences, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Sight Sciences wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
👍️0
RC_702 RC_702 6 months ago
Perhaps JP and others dumped their shares because of this:

Sight Sciences Insiders Are Selling The Stock
Over the last three months, we've seen significant insider selling at Sight Sciences. In total, insiders sold US$244k worth of shares in that time, and we didn't record any purchases whatsoever.

I guess that’s what you could consider a good call
👍️0
RC_702 RC_702 6 months ago
Sorry, but it was not my call. I’m not an expert but I can read what the experts have stated

I guess you’re referring to JP Morgan dumping all of their shares recently being a good call
👍️0
Southern Gal Southern Gal 6 months ago
GOOD CALL!!!
12 Month Price Target usd 6.10
Based on 4 analysts
Price Volatility. High
Last updated: 6/12/2024
On 6/12 the PPS closed @ $6.86

On Friday the PPS closed @ $7.61

That's more than a 10% gain in 1 month

Oh, and BTW, a 25% gain for my $2.98 shares.
👍️0
Southern Gal Southern Gal 6 months ago
it seems they were all wrong to sell and forecast lower
Closed on Friday at an 11 month high PPS

I'm laughing all the way to the bank
1 YEAR CHART
👍️0
RC_702 RC_702 6 months ago
Or perhaps it was:

Operating Income % is Gross Profit minus Operating Expenses. Shown as a percentage of Revenue. A good indicator of profitability. Higher is better.

SGHT OI
2023 - 77.06 %
2022 - 117.70%

Or:

Net Profit % shows how much of each dollar in Revenue translates into Profit. Shown as a percentage of Revenue. Higher is better.

SGHT Net Profit
2023 -68.53%
2022 - 120.90%

And analysts say that they are not going to be profitable for at least three years
👍️0
RC_702 RC_702 6 months ago
Perhaps it was this:

12 Month Price Target usd 6.10
Based on 4 analysts
Price Volatility. High
Last updated: 6/12/2024
Industry Recommendation. Hold
👍️0
RC_702 RC_702 6 months ago
What do they know about the company that made them dump the stock recently?

JPMorgan Chase decreased stake by 12.86% to
👍️0
Southern Gal Southern Gal 6 months ago
LMAO!!!

UP 30% since your post.
👍️0
RC_702 RC_702 7 months ago
Earnings Trend: SGHT is unprofitable, and losses have increased over the past 5 years at a rate of 15.5% per year.
👍️0
RC_702 RC_702 7 months ago
Insider trading , why did:
D1 capital partners LD on 26 Dec23
Sell $16,712,931 of sight sciences?
Entity: company
Shares: 2,852,036
Max Price: $5.86
👍️0
RC_702 RC_702 7 months ago
Sight Sciences Insiders Are Selling The Stock
Over the last three months, we've seen significant insider selling at Sight Sciences. In total, insiders sold US$244k worth of shares in that time, and we didn't record any purchases whatsoever.
Yahoo finance June 14, 2024
👍️0
RC_702 RC_702 7 months ago
Sight Sciences Insiders Are Selling The Stock
Over the last three months, we've seen significant insider selling at Sight Sciences. In total, insiders sold US$244k worth of shares in that time, and we didn't record any purchases whatsoever.
Yahoo finance June 14, 2024
👍️0
Monksdream Monksdream 7 months ago
SGHT under $10
👍️0
Southern Gal Southern Gal 7 months ago
Wow- somebody took a bunch of profit in the last minutes. First down day is quite a while
👍️0
Southern Gal Southern Gal 7 months ago
And another up day.
👍️0
Southern Gal Southern Gal 7 months ago
First time SGHT closed above $7 in over 6 months!!!
👍️0
Southern Gal Southern Gal 8 months ago
She broke through seven dollars. very strong volume today. So bright I gotta wear shades
👍️0
Southern Gal Southern Gal 8 months ago
Good news...

creates big gains. Blue skies ahead. My $2.98's have doubled+
👍️0

Your Recent History

NASDAQ
SGHT
Sight Sciences
BIT
1CVA
Cleveland Cliffs
NASDAQ
FEAKX
Bmo Retirement Balanced ...
TG
A19RCW
Procter and Gamble
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads